FDA approves Bayer’s Finerenone for new indication in patients with HF and LVEF of ?40%
Finerenone significantly reduced the combined risk of cardiovascular death and total (first and recurrent) heart failure events,
Finerenone significantly reduced the combined risk of cardiovascular death and total (first and recurrent) heart failure events,
The program will offer a structured and immersive learning experience for over 20,000 healthcare professionals across more than 10 cities
The global TCIM market is expected to reach nearly US$ 600 billion by 2025
Celecoxib is a nonsteroidal anti-inflammatory drug
In collaboration with the Gates Foundation, Merck advances MK-8527 pre-exposure prophylaxis (PrEP) clinical trials globally
The company’s largest center for medical device applications, serving the entire Asian market
The Medical Countermeasures Strategy focuses on strengthening the EU’s preparedness for health crises
IGI partners with AbbVie and grants exclusive rights to globally develop, manufacture, and commercialize ISB 2001 across North America, Europe, Japan, and Greater China
Azelis will strengthen its presence in the domestic market by leveraging portfolio synergies, actively consolidating the business, and creating value for all stakeholders
This year, 40 women students are participating, selected through a rigorous process evaluating academic merit, research interest, and socio-economic background
Subscribe To Our Newsletter & Stay Updated